|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 17, 2017 ) According to Publisher, the Global Organ Preservation market is estimated at $153.93 million in 2015 and is expected to reach $274.19 million by 2022 growing at a CAGR of 8.7% from 2015 to 2022. Organ failure cases in ageing population, Organ donation campaign by government and other organisations are the key factors driving the market growth. Huge cost associated with organ transplantation is hampering the market. Technological advancements in organ preservation seems to be opportunity for the market to grow.
By preservation solution, custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) solution accounted for the largest share because of its property to preserve various organs like liver, lung, heart and more. By technique, static cold storage (SCS) holds the largest share, whereas hypothermic machine perfusion technique is expected to move at highest CAGR due to high demand for organs and less availability. Europe is the largest market for Organ Preservation and Asia Pacific is anticipated to register significant CAGR during the forecast period.
For more information @ http://www.reportsweb.com/organ-preservation-global-market-outlook-2016-2022
Some of the key players in the market include Teva Pharmaceutical Industries Ltd., Dr. Franz Kohler Chemie GmbH, Xvivo Perfusion AB, Claris Lifesciences Limited, Paragonix Technologies, Inc., Transmedics, Inc., 21st Century Medicine Inc., Bridge to Life Limited, Essential Pharmaceuticals, LLC, Waters Medical Systems LLC [Institut Georges Lopez (IGL], Preservation Solutions, Inc., Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.), Organox Limited, Bristol-Myers Squibb and ToleroTech, Inc.
Organ Types Covered:
- Heart
- Kidneys
- Lung
- Liver
- Other Organs
o Pancreas
o Intestine
Techniques Covered:
- Normothermic Machine Perfusion
- Static Cold Storage (SCS) Technique
- Hypothermic Machine Perfusion
Solutions Covered:
- Perfadex
- Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution
- University of Wisconsin Solution (UW Solution)
- Human bioSystem (HBS) Solution
- Hypothermosol
- siRNA Transplant Solution
- Viaspan
- Renograf
- Lifor
- Other Preservation Solutions
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001565006/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
10 Company Profiling
10.1 Teva Pharmaceutical Industries Ltd.
10.2 Dr. Franz Kohler Chemie GmbH
10.3 Xvivo Perfusion AB
10.4 Claris Lifesciences Limited
10.5 Paragonix Technologies, Inc.
10.6 Transmedics, Inc.
10.7 21st Century Medicine Inc.
10.8 Bridge to Life Limited
10.9 Essential Pharmaceuticals, LLC
10.10 Waters Medical Systems LLC [Institut Georges Lopez (IGL]
10.11 Preservation Solutions, Inc.
10.12 Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
10.13 Organox Limited
10.14 Bristol-Myers Squibb
10.15 ToleroTech, Inc.
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001565006/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
